PeptideDB

Cbl-b-IN-19

CAS: F: C34H31F3N8O W: 624.66

Cbl-b-IN-19 (Compound 49) is an inhibitor for casitas B-lineage lymphoma b(Cbl-b), that inhibits Cbl-b phosphorylation w
Sales Email:peptidedb@qq.com

This product is for research use only, not for human use. We do not sell to patients.

Bioactivity Cbl-b-IN-19 (Compound 49) is an inhibitor for casitas B-lineage lymphoma b(Cbl-b), that inhibits Cbl-b phosphorylation with an IC50 < 100 nM[1].
Formula C34H31F3N8O
Molar Mass 624.66
Transport Room temperature in continental US; may vary elsewhere.
Storage

Please store the product under the recommended conditions in the Certificate of Analysis.

Reference [1]. Murugan C, et al., Bicyclic heterocyclic compounds as cbl-b inhibitors. WO2024062363A1.